International Graphite (IG6:AU) has announced Graphite Purification Tolling Services Download the PDF here. This post appeared first on investingnews.com
Investing
-
-
The silver price reached heights not seen in more than 40 years in 2025, posting new all-time highs in the fourth quarter amid a supply deficit, expanding industrial use and rising safe-haven demand. The white…
-
American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) has successfully completed another critical stage in its mineral processing program by producing a mixed rare earths oxide (“MREO”) using…
-
LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’ or ‘Issuer’) is pleased to announce a non-brokered private placement offering of up to 6,000,000 units of the Company (the ‘Units’) at a…
-
US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told…
-
-
Perth, Australia (ABN Newswire) – Locksley Resources Limited (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced the appointment of Lieutenant General (Ret.) Mark C. Schwartz as Strategic Advisor – U.S. Government Initiatives, strengthening the Company’s engagement across U.S. defense,…
-
2026 is poised to be transformative for uranium as tightening supply converges with robust demand from new reactor builds and life extensions, plus data center construction and a broader shift to clean energy. Despite these…
-
Investing
Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million
by adminSun Summit Minerals Corp. (TSXV: SMN,OTC:SMREF) (OTCQB: SMREF) (‘Sun Summit’ or the ‘Company’) is pleased to announce that, due to significant investor demand, it has increased the maximum gross proceeds of its previously announced non-brokered private placement…
-
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement.…
